Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-17-000411)

Filing Details

Accession Number:: 0001493152-17-000411
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-01-12 17:22:27
Reporting Period:: 2017-01-11

Filing Date:: 2017-01-12
Accepted Time:: 2017-01-12 17:22:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1335105	Lixte Biotechnology Holdings Inc.	LIXT	Pharmaceutical Preparations (2834)	202903526

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1472409	Gil Schwartzberg	5500 Military Trail, Suite 22 Jupiter FL 333458		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-01-11	1,005,556	$0.06	9,133,539	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Footnotes

The shares were acquired by The Gil & Debbie Schwartzberg Family Trust dated November 19, 2003, Gil N. Schwartzberg Separate Property.